Table 3 Levels of oxidative stress markers of participants before intervention
|  | Placebo (N = 28) | Supplement (N = 30) | p |
|---|---|---|---|
LagTime (min) | 56.0 ± 20.4 | 53.0 ± 12.6 | 0.5 |
Isoprostane(ng/mmol creatinine) | 75.1 (47.5—261.1) | 96.1 (52.1–236.7) | 0.4 |
TBARS (μM) | 5.21 ± 1.22 | 5.05 ± 1.59 | 0.6 |
oxLDL (μg/mL) | 1.23 (0.681–2.35) | 1.54 (1.01–2.31) | 0.1 |
8-hydroxy-2΄- deoxyguanosine (μg/mmol creatinine) | 10.5 (5.23–21.4) | 12.0 (8.36–16.5) | 0.9 |
Protein Carbonyls (nmol/mg protein | 81.1 (61.3–93.7) | 95.3 (70.6–133.1) | 0.04 |
Gpx activity (U/mL) | 0.0826 (0.0734–0.0964) | 0.0911 (0.0774–0.0911) | 0.4 |
SOD activity (U/mg) | 16.8 (9.64–27.1) | 18.2 (11.2–25.5) | 0.6 |